This inventor holds 3 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents. Top assignee: Indivior UK Limited. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Richmond, VA (US) (2021)
- North Chesterfield, VA (US) (2023)
Company Filing History:
Years Active: 2021-2026
Title: Christian A Heidbreder: Innovator in Buprenorphine Dosing Regimens
Introduction
Christian A Heidbreder is a notable inventor based in North Chesterfield, VA (US). He has made significant contributions to the field of medicine, particularly in the development of dosing regimens for buprenorphine. With a total of 3 patents to his name, Heidbreder's work focuses on improving therapeutic outcomes for patients dealing with pain and opioid use disorders.
Latest Patents
Heidbreder's latest patents revolve around buprenorphine dosing regimens. The disclosures provide a dosage regimen using sustained-release buprenorphine formulations to achieve therapeutic levels of buprenorphine in patients. This innovation is crucial for the effective treatment of pain and opioid use disorders, showcasing Heidbreder's commitment to enhancing patient care.
Career Highlights
Christian A Heidbreder is currently associated with Indivior UK Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in buprenorphine formulations has positioned him as a key player in the development of effective treatment strategies.
Collaborations
Heidbreder collaborates with talented professionals in his field, including Azmi Nasser and Celine M Laffont. Their combined efforts contribute to the advancement of research and development in medication therapies.
Conclusion
Christian A Heidbreder's contributions to buprenorphine dosing regimens highlight his dedication to improving patient outcomes in the treatment of pain and opioid use disorders. His innovative work continues to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
